Full Text View
Tabular View
No Study Results Posted
Related Studies
An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
This study has been terminated.
( program discontinued based on GIPF-007 results )
Study NCT00076635   Information provided by InterMune
First Received: January 28, 2004   Last Updated: November 2, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis
Lung Disease
Additional conditions recognized in this trial
Fibrosis
Lung Diseases
More general conditions related to this trial
Lung Diseases, Interstitial
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Interferon gamma-1b
Additional drug interventions recognized in this trial
Interferon Type II
Interferon-gamma, Recombinant
Interferons
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
InterMune


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services